Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Canadian Retrospective Study Evaluating Longitudinal SEMAglutide Use on Cardio-Kidney-Metabolic Outcomes

NCT07424430 is registered in ClinicalTrials.gov with LMC Diabetes & Endocrinology Ltd. as lead sponsor.

NCT NCT07424430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07424430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Canadian Retrospective Study Evaluating Longitudinal SEMAglutide Use on Cardio-Kidney-Metabolic Outcomes
Lead sponsor
LMC Diabetes & Endocrinology Ltd.
Phase
Observational
Overall status
Completed
Start date
February 20, 2026
Completion date
September 28, 2026
Enrollment
3,392 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes (dm), obesity (disorder), type 2 diabetes